AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tarolus 0.1% Lotion

Prescription Icon
Prescription Required

Marketer

Symbiosis Pharmaceuticals Pvt Ltd

Salt Composition

Tacrolimus (0.1% w/v)

Overview Tarolus 0.1% Lotion

Eczema (atopic dermatitis) is treated with Tarolus 0.1% Lotion, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Tarolus 0.1% Lotion externally, 2–4 times daily to affected areas, or as directed by your physician. Gently and evenly rub it into the skin. Avoid overuse and do not bandage or cover treated skin. Report lack of improvement after two weeks or worsening skin condition to your doctor. Common side effects may include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Unless absolutely necessary, this medication is generally not recommended during pregnancy or breastfeeding.

Uses of Tarolus 0.1% Lotion

Managing atopic dermatitis

Major Benefits of Tarolus 0.1% Lotion:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Ensure thorough shaking before applying a uniform layer to the affected area.

Common Side effects of Tarolus 0.1% Lotion:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tarolus 0.1% Lotion:

Apply this medication only to the skin's surface. Follow your doctor's instructions precisely regarding dosage and treatment length. Ensure thorough mixing before applying a uniform layer to the affected area.

How Tarolus 0.1% Lotion works:

Tarolus 0.1% Lotion, an immunosuppressant medication, reduces skin inflammation (redness and swelling) by inhibiting the activity of specific immune cells. This action alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No drug interaction detected.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tarolus 0.1% Lotion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to recommending this lotion. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Tarolus 0.1% Lotion while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Tarolus 0.1% Lotion :

Should you forget a Tarolus 0.1% Lotion application, use it immediately. Nevertheless, if your next scheduled application is imminent, omit the missed one and resume your usual dosing regimen.

Facts to Know About Tarolus 0.1% Lotion

LabelValue
Chemical Category Macrolide-Lactam Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Behavior Class Calcineurin inhibitor immunosuppressants

FAQs on Tarolus 0.1% Lotion

Tarolus 0.1% Lotion is an immunomodulatory medicine that primarily reduces immune system activity. It treats moderate to severe atopic dermatitis (eczema) in adults whose condition is unresponsive to, or adversely affected by, steroid treatments. By modulating the overactive immune response responsible for skin inflammation in atopic dermatitis, Tarolus 0.1% Lotion alleviates itching, redness, and dryness.
Applying Tarolus 0.1% Lotion may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These typically resolve within a week. Use may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tarolus 0.1% Lotion offers safe and effective short-term atopic dermatitis treatment, demonstrating superior safety compared to other immunosuppressants. Its minimal systemic absorption after topical application results in fewer side effects than oral immunosuppressants.
Tarolus 0.1% Lotion is not a controlled substance because it lacks abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Prolonged use of Tarolus 0.1% Lotion may increase the risk of lymphoma, a type of lymph node tumor. Studies have linked Tarolus 0.1% Lotion and similar medications to a small number of skin cancer and lymphoma cases. If using Tarolus 0.1% Lotion for over six weeks, or if your eczema worsens or fails to improve, consult your doctor.
Tarolus 0.1% Lotion is a non-steroidal medication that modulates the immune system. Primarily used to treat eczema, particularly atopic dermatitis, it avoids the skin thinning and other side effects associated with steroids.
Tarolus 0.1% Lotion
268
MRP 327
18% off